An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by ...

The exact cause of AVMs is not known. Experts believe that they can result from developmental errors that occur during ...

The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...

Dr Ray O’Connor takes a look at the latest clinical articles on inflammatory bowel disease ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Recessive dystrophic epidermolysis bullosa (RDEB) is a systemic disease of poor mucocutaneous basement membrane integrity downstream of bi-allelic pathogenic variants in COL7A1. Cutaneous clinical ...

A panelist discusses how real-world experience with ruxolitinib and belumosidil shows similar response rates to clinical ...

New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...

Face yoga has gained online popularity in recent years for its promised antiaging, face slimming effects, but does it ...

New guidelines published today, developed and led by experts at the University of Nottingham, will help clinicians to better ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

There has been no or some progress in most areas since a National Institute of Health consensus development project in 2020, according to a group of experts. But exception is important: Prevention of ...